Metasphere Labs Inc.
LABZ
CNSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.80K | -- | 158.80K | 498.30K | 482.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.80K | -- | 158.80K | 498.30K | 482.00K |
| Cost of Revenue | 15.00K | -- | 25.50K | 91.60K | 71.40K |
| Gross Profit | 900.00 | -- | 133.40K | 406.60K | 410.60K |
| SG&A Expenses | 72.50K | 182.20K | 282.00K | 275.00K | 65.10K |
| Depreciation & Amortization | -- | -- | 32.70K | 30.00K | 4.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 87.60K | 197.60K | 360.20K | 396.60K | 141.10K |
| Operating Income | -71.70K | -197.60K | -201.40K | 101.70K | 340.80K |
| Income Before Tax | -79.60K | -219.20K | -743.90K | 150.20K | 373.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -79.60K | -219.20K | -743.90K | 150.20K | 373.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -79.60K | -219.20K | -743.90K | 150.20K | 373.40K |
| EBIT | -71.70K | -197.60K | -201.40K | 101.70K | 340.80K |
| EBITDA | -67.30K | -193.10K | -196.80K | 106.30K | 345.50K |
| EPS Basic | 0.00 | -0.01 | -0.02 | 0.00 | 0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| EPS Diluted | 0.00 | -0.01 | -0.02 | 0.00 | 0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Average Basic Shares Outstanding | 41.79M | 37.08M | 30.73M | 40.20M | 16.99M |
| Average Diluted Shares Outstanding | 41.79M | 37.08M | 30.73M | 56.49M | 29.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
